Partnering for Global Health Forum 2008 to Create a New Paradigm for Addressing Most Pressing Global Health Issues

• Contact: Contact Tracy Krughoff
  202.312.9274,

WASHINGTON, D.C. (Thursday, January 24, 2008) - The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) are pleased to announce that Anthony Fauci, MD, of NIH’s National Institute of Allergy and Infectious Diseases will be delivering a roundtable on global health from bench to bedside, and Cheryl Scott of the Bill & Melinda Gates Foundation will be delivering a fireside chat on global health issues at the Partnering for Global Health Forum, co-sponsored by the Gates Foundation.<?xml:namespace prefix = o />

“We’re bringing leaders in the biotechnology and pharmaceutical industries together with pioneers in global health to create a new paradigm for developing medicines that will save lives around the world,” said Jim Greenwood, president and CEO of BIO. 

Additional conference speakers include Joshua Boger, PhD, founder, president and CEO of Vertex Pharmaceuticals; Joerg Reinhardt, PhD, CEO of Vaccines and Diagnostics at Novartis Pharmaceuticals; Henri Termeer, president and CEO of Genzyme Corporation; Chris Hentschel, PhD, president and CEO of the Medicines for Malaria Venture; and Gary M. Cohen, president of BD Medical, BD. More speaker information can be found at www.pghforum.org.  

Attendees will address the pressing needs for innovation and explore new avenues for progress through sessions focusing on market incentives, innovative business models, and partnerships between the public and private sectors.

“This meeting offers attendees the opportunity to share ideas on how best to develop and disseminate medicines to patients in the developing world, and how we can work together as an industry to accelerate the process" said BVGH President and CEO Dr. Christopher D. Earl.

The Forum will feature an open exchange with world-renowned leaders in global health, industry, government and the donor community; opportunities to meet one-on-one with leading companies, researchers, donors and investors; presentations from innovators pursuing technologies and products applicable to diseases of the developing world; and perspectives from public and private funders supporting global health R&D.

For more information and to register, visit www.pghforum.org.

About BVGH

BIO Ventures for Global Health (BVGH), a non-profit organization, is harnessing the resources of the biotechnology industry to create new medicines for neglected diseases of the developing world. Our mission is to break down barriers that hinder industry involvement in global health product development and to catalyze new industry investment.  www.bvgh.org <https://mail.bio.org/exchweb/bin/redir.asp?URL=http://www.bvgh.org/>   

About BIO

BIO represents more than 1,150 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the <?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. BIO also produces the annual BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. www.bio.org  

Upcoming BIO Events

 ·   BIO-Asia Partnering Conference 
    January 28-29, 2008
    Tokyo, Japan

 ·   BIO CEO & Investor Conference 
    February 11-13, 2008
    New York, NY

 ·   Partnering for Global Health  
    March 10-12, 2008
    Washington, DC

 ·   BIO-Europe Spring 
    April 7-9, 2008
    Madrid, Spain

 ·   BIO National Venture Conference 
    April 22-23, 2008
    Boston, Mass.

 ·   World Congress on Industrial Biotechnology & Bioprocessing  
    April 27-30, 2008
    Chicago, Ill.

 ·   2008 BIO International Convention 
    June 17-20, 2008
    San Diego, Calif.

###